Erratum to "Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration"
- PMID: 34081321
- DOI: 10.1002/cncr.33544
Erratum to "Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration"
Erratum for
-
Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration.Cancer. 2020 Oct 1;126(19):4390-4399. doi: 10.1002/cncr.33095. Epub 2020 Jul 22. Cancer. 2020. PMID: 32697362
Publication types
LinkOut - more resources
Full Text Sources